387 related articles for article (PubMed ID: 21965338)
1. Insight into the heterogeneity of breast cancer through next-generation sequencing.
Russnes HG; Navin N; Hicks J; Borresen-Dale AL
J Clin Invest; 2011 Oct; 121(10):3810-8. PubMed ID: 21965338
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
3. A new genome-driven integrated classification of breast cancer and its implications.
Dawson SJ; Rueda OM; Aparicio S; Caldas C
EMBO J; 2013 Mar; 32(5):617-28. PubMed ID: 23395906
[TBL] [Abstract][Full Text] [Related]
4. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
5. Clinical target sequencing for precision medicine of breast cancer.
Tsuchida J; Rothman J; McDonald KA; Nagahashi M; Takabe K; Wakai T
Int J Clin Oncol; 2019 Feb; 24(2):131-140. PubMed ID: 30604156
[TBL] [Abstract][Full Text] [Related]
6. Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
Nakauchi C; Kagara N; Shimazu K; Shimomura A; Naoi Y; Shimoda M; Kim SJ; Noguchi S
Clin Breast Cancer; 2016 Oct; 16(5):418-423. PubMed ID: 27265061
[TBL] [Abstract][Full Text] [Related]
7. The breast cancer genome--a key for better oncology.
Vollan HK; Caldas C
BMC Cancer; 2011 Nov; 11():501. PubMed ID: 22128823
[TBL] [Abstract][Full Text] [Related]
8. Next-Generation Sequencing-Based Biomarkers in Breast Cancer.
Han W; Lim W
Adv Exp Med Biol; 2021; 1187():323-335. PubMed ID: 33983586
[TBL] [Abstract][Full Text] [Related]
9. Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer.
Kim RN; Moon HG; Han W; Noh DY
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414922
[TBL] [Abstract][Full Text] [Related]
10. Genetic heterogeneity in breast cancer: the road to personalized medicine?
Baird RD; Caldas C
BMC Med; 2013 Jun; 11():151. PubMed ID: 23800221
[TBL] [Abstract][Full Text] [Related]
11. Targeted mutation detection in breast cancer using MammaSeq™.
Smith NG; Gyanchandani R; Shah OS; Gurda GT; Lucas PC; Hartmaier RJ; Brufsky AM; Puhalla S; Bahreini A; Kota K; Wald AI; Nikiforov YE; Nikiforova MN; Oesterreich S; Lee AV
Breast Cancer Res; 2019 Feb; 21(1):22. PubMed ID: 30736836
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
[TBL] [Abstract][Full Text] [Related]
13. Dynamic genome and transcriptional network-based biomarkers and drugs: precision in breast cancer therapy.
Kyrochristos ID; Ziogas DE; Roukos DH
Med Res Rev; 2019 May; 39(3):1205-1227. PubMed ID: 30417574
[TBL] [Abstract][Full Text] [Related]
14. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
15. Genomic Pathology and Biomarkers in Breast Cancer.
Zhang Z; Tang P
Crit Rev Oncog; 2017; 22(5-6):411-426. PubMed ID: 29604921
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
17. Tumoral heterogeneity of breast cancer.
Roulot A; Héquet D; Guinebretière JM; Vincent-Salomon A; Lerebours F; Dubot C; Rouzier R
Ann Biol Clin (Paris); 2016 Dec; 74(6):653-660. PubMed ID: 27848916
[TBL] [Abstract][Full Text] [Related]
18. Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
Stover DG; Wagle N
Curr Oncol Rep; 2015 Apr; 17(4):15. PubMed ID: 25708799
[TBL] [Abstract][Full Text] [Related]
19. Intratumor Heterogeneity in Breast Cancer.
Beca F; Polyak K
Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
[TBL] [Abstract][Full Text] [Related]
20. Next generation analysis of breast cancer genomes for precision medicine.
Previati M; Manfrini M; Galasso M; Zerbinati C; Palatini J; Gasparini P; Volinia S
Cancer Lett; 2013 Oct; 339(1):1-7. PubMed ID: 23879964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]